Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03QXD
|
||||
Former ID |
DIB004981
|
||||
Drug Name |
RXP-470
|
||||
Synonyms |
RXP-470; MMP-12 inhibitors (atherosclerosis); MMP-12 inhibitors (atherosclerosis), CEA; RXP-470 derivatives (atherosclerosis), CEA
|
||||
Indication | Atherosclerosis [ICD9: 414.0, 440; ICD10:I70] | Investigative | [543453] | ||
Company |
Commissariat a l`Energie Atomique
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1(c2cc(on2)C[C@H](CP(=O)(O)c2ccc(cc2)Br)C(=O)N[C@H](C(<br />=O)N[C@H](C(=O)N)CCC(=O)O)CCC(=O)O)ccc(cc1)c1cccc(c1)Cl
|
||||
Target and Pathway | |||||
Target(s) | MMP-12 | Target Info | Inhibitor | [543453] | |
NetPath Pathway | IL1 Signaling Pathway | ||||
IL5 Signaling Pathway | |||||
Pathway Interaction Database | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.